tradingkey.logo
搜尋

Rxsight Inc

RXST
添加自選
5.610USD
+0.440+8.51%
收盤 07/02, 13:00美東報價延遲15分鐘
232.23M總市值
虧損本益比TTM

Rxsight Inc

5.610
+0.440+8.51%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+8.51%

5天

+9.36%

1月

+13.56%

6月

-45.95%

今年開始到現在

-46.16%

1年

-57.31%

關鍵數據
5.140今開
5.670最高
3.55M成交量
虧損本益比TTM
虧損本益比動
--股利TTM
8.61%換手率
5.170昨收
5.140最低
17.57M成交額
虧損本益比靜
0.84市淨率
0.00%股息率 TTM
-15.12%ROA
26.38052週最高
2.65量比
-27.45M淨利潤
41.24M總股本
-1.1357每股盈餘TTM
1.21Beta
-17.06%ROE
5.90052週最低
10.24%振幅
76.06%毛利率
232.23M總市值
1.95回報/風險
4.07%風險率

TradingKey Rxsight Inc股票評分

單位: USD 更新時間: 2026-07-02

操作建議

Rxsight Inc當前公司基本面數據相對健康,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名83/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為8.93。中期看,股價處於下降通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Rxsight Inc評分

相關信息

行業排名
83 / 204
全市場排名
194 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Rxsight Inc亮點

亮點風險
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
業績高增長
公司營業收入穩步增長,連續3年增長50.97%
估值高估
公司最新PE估值-4.94,處於3年歷史高位
機構減倉
最新機構持股38.60M股,環比減少22.17%
活躍度增加
近期活躍度增加,過去20天平均換手率0.55

分析師目標

基於 10 分析師
持有
評級
8.929
目標均價
+75.07%
漲幅空間

Rxsight Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Rxsight Inc簡介

RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
公司代碼RXST
公司Rxsight Inc
CEOKurtz (Ron M)
網址https://www.rxsight.com/

常見問題

Rxsight Inc(RXST)的當前股價是多少?

Rxsight Inc(RXST)的當前股價是 5.61。

Rxsight Inc 的股票代碼是什麼?

Rxsight Inc的股票代碼是RXST。

Rxsight Inc股票的52週最高點是多少?

Rxsight Inc股票的52週最高點是26.38。

Rxsight Inc股票的52週最低點是多少?

Rxsight Inc股票的52週最低點是5.90。

Rxsight Inc的市值是多少?

Rxsight Inc的市值是231.37M。

現在Rxsight Inc(RXST)的股票是買入、持有還是賣出?

根據分析師評級,Rxsight Inc(RXST)的總體評級為signal_hold,目標價格為8.93。

Rxsight Inc(RXST)股票的每股收益(EPS TTM)是多少

Rxsight Inc(RXST)股票的每股收益(EPS TTM)是-0.95。